Mercury Laboratories (BOM:538964) E10: ₹40.30 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:538964 Mercury Laboratories Ltd BOM:538964
76 GF Score
Price ₹812.50
GF Value ₹832.71
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Mercury Laboratories E10?

Mercury Laboratories BOM:538964 +4.57% 76 E10 is ₹40.30 as of Jun. 2026. GuruFocus rates BOM:538964 with a GF Score™ of 76/100 and a GF Value™ of ₹832.71 (Fairly Valued). The stock has 5 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Mercury Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was ₹2.480. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹40.30 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Mercury Laboratories's average E10 Growth Rate was -6.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-08-05), Mercury Laboratories's current stock price is ₹812.50. Mercury Laboratories's E10 for the quarter that ended in Jun. 2026 was ₹40.30. Mercury Laboratories's Shiller PE Ratio of today is 20.16.

During the past 13 years, the highest Shiller PE Ratio of Mercury Laboratories was 28.88. The lowest was 17.47. And the median was 20.07.


Mercury Laboratories  (BOM:538964) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Mercury Laboratories's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=812.50/40.30
=20.16

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Mercury Laboratories was 28.88. The lowest was 17.47. And the median was 20.07.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Mercury Laboratories E10 Related Terms


Mercury Laboratories E10 Historical Data

* Premium members only.

The historical data trend for Mercury Laboratories's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mercury Laboratories E10 Chart

Mercury Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 43.41 42.93 40.82

Mercury Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 42.98 43.65 40.32 40.82 40.30

BOM:538964 vs ZTS: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Mercury Laboratories's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mercury Laboratories Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mercury Laboratories's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Mercury Laboratories's Shiller PE Ratio falls into.


BOM:538964
76GF Score
Mercury Laboratories Ltd BOM:538964
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mercury Laboratories E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Mercury Laboratories's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.48/166.1454*166.1454
=2.480

Current CPI (Jun. 2026) = 166.1454.

Mercury Laboratories Quarterly Data

per share eps CPI Adj_EPS
201609 7.000 105.961 10.976
201612 2.970 105.196 4.691
201703 4.710 105.196 7.439
201706 -11.400 107.109 -17.684
201709 14.020 109.021 21.366
201712 10.950 109.404 16.629
201803 3.210 109.786 4.858
201806 6.770 111.317 10.105
201809 6.860 115.142 9.899
201812 8.170 115.142 11.789
201903 1.830 118.202 2.572
201906 8.320 120.880 11.436
201909 8.800 123.175 11.870
201912 12.730 126.235 16.755
202003 -2.950 124.705 -3.930
202006 8.010 127.000 10.479
202009 13.790 130.118 17.608
202012 16.960 130.889 21.528
202103 5.720 131.771 7.212
202106 10.380 134.084 12.862
202109 8.030 135.847 9.821
202112 4.340 138.161 5.219
202203 6.930 138.822 8.294
202206 12.190 142.347 14.228
202209 26.190 144.661 30.080
202212 5.050 145.763 5.756
202303 3.050 146.865 3.450
202306 8.330 150.280 9.209
202309 26.190 151.492 28.723
202312 10.300 152.924 11.190
202403 15.920 153.035 17.284
202406 2.850 155.789 3.039
202409 4.170 157.882 4.388
202412 9.940 158.323 10.431
202503 9.250 157.552 9.755
202506 8.060 159.755 8.382
202509 13.690 162.289 14.015
202512 8.310 163.281 8.456
202603 10.210 164.272 10.326
202606 2.480 166.145 2.480

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹40.30 mean?
Mercury Laboratories (BOM:538964) has a E10 of ₹40.30 as of Jun. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mercury Laboratories and its competitors.
Is Mercury Laboratories' E10 too high?
Mercury Laboratories' current E10 is ₹40.30. Overall, Mercury Laboratories has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercury Laboratories' E10 compare to ZTS?
Mercury Laboratories' E10 of ₹40.30 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Mercury Laboratories and its competitors. Mercury Laboratories's current E10 is ₹40.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercury Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Mercury Laboratories (BOM:538964) is currently considered Fairly Valued. The stock's GF Value™ is ₹832.71, compared to a current price of ₹812.50 — trading 2.4% below its estimated fair value. The current E10 is ₹40.30. Mercury Laboratories' overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Mercury Laboratories (BOM:538964), the current E10 is ₹40.30 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mercury Laboratories (BOM:538964) Overvalued in 2026?

Based on GuruFocus' analysis, Mercury Laboratories stock appears to be undervalued. The current stock price of ₹812.50 is trading 2.4% below its estimated GF Value™ of ₹832.71. GuruFocus considers Mercury Laboratories to be Fairly Valued.

Key valuation signals for BOM:538964:

  • E10: ₹40.30
  • GF Value™: ₹832.71 vs. price of ₹812.50 (2.4% below fair value)
  • GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the BOM:538964 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mercury Laboratories Business Description

Address Gorwa Road, 2/13-14, Gorwa Industrial estate, P.B. No. 3001, Vadodara, GJ, IND, 390016
Mercury Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and distribution of pharmaceutical drugs, herbs, and laboratory and surgical materials. The group produces medicines and formulations in the segments of pediatrics, obstetrics, gynecology, surgeon segment, multivitamin and nutrition supplements, antibiotics, and others. The company sells its products in India and Internationally, of which key revenue is derived from sales made in India.
76GF Score

Get the complete analysis for BOM:538964

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹812.50
Price
₹832.71
GF Value